PharmaVOICE, US: Cognizant’s SVP and Global Markets Leader, Life Sciences Discusses How Digital Delivers New Therapeutics and Personalized Medicine

“Digital Mastery will result in renewed opportunities for life sciences companies to forge deeper connections in the currently fragmented industry, collaborate more fully with value chain participants and drive better health outcomes for patients,” writes Bhaskar Sambasivan.  Excerpts:

“To unlock digital’s business value, however, new interplays are needed among the life-sciences ecosystem — sponsors, CROs, investigators, healthcare payers, providers, and patients — to more effectively mine and apply meaning from data flows, and optimize processes long overdue for a digital refresh. Analyzable data, rich with meaning, is driving a connected future for healthcare, and life-sciences companies have an important role to play as orchestrators of value.

Sensors, smart processes and smart drugs will impact how life-sciences companies collaborate to create value. Clinicians and data scientists, using digital tools and approaches, can already orchestrate tasks, merging and analyzing data sets from drug trials and direct observations from other physicians, electronic medical records, online patient networks, or genomics research. New, simpler data visualization tools will help ensure that doctors and scientists can visualize data without technical assistance and interpret what they see on their screens.

By effectively harnessing the wealth of data they generate — and collaborating with ecosystem stakeholders — pharma and medical device manufacturers can transform the clinical trials experience, empower patients with data-driven processes and platforms, and achieve operational excellence."

Click here to read the article.